Search Browse Earnings

vTv Therapeutics Inc. — SlamSEC

vTv Therapeutics Inc.

Nasdaq:VTVT

Pharmaceutical Preparations·HIGH POINT, NC

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$0

-100.0% YoY

FY 2025

Adj. EBITDA

-$25.4M

FY 2025

Net Income

-$20.3M

FY 2025

EPS (Diluted)

—

Stock Price

$34.80

-4.5%

2026-03-10

52W Range

$14.00 – $44.00

P/E Ratio

—

Market Cap

—

Cash

$36.7M

FY 2025

Total Debt

$2.2M

FY 2015

Net Cash

$34.6M

FY 2015

Enterprise Value

—

Debt / EBITDA

1.4x

FY 2025

EV / EBITDA

—

Employees

—

CEO

Sekhri Paul J

CFO

Tung Michael Stephen